Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Anaesthetic Methods for Total Knee Replacement Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has a diagnosis of rheumatoid or osteoarthritis and listed for a primary total knee replacement.~* Participant is willing and able to give informed consent for participation in the study.~* Male or Female, aged between 18 and 85 years.~* American Society of Anesthesiologists (ASA) score I-III~* Able (in the clinical staff's opinion) and willing to comply with all study requirements.~* Willing to allow his or her General Practitioner and consultant, if appropriate, to be noti-fied of participation in the study.~Exclusion Criteria:~* Patient refusal~* Chronic pain (defined as consumption of \>480mg codeine/24hrs or ANY regular strong opiate consumption by the oral/transdermal route)~* Patients aged \<18 or \>85~* ASA score \>III~* Body mass index (BMI) \>35~* Lacking mental capacity to give consent to enter trial/undergo surgery~* Contraindications to catheter placement (coagulopathy , systemic sepsis or infection at placement site, pre-existing neuropathy) or any other component to the study treatment pathway.~* Participant who is terminally ill~* Allergy/intolerance to study medications~* Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Group F (Type: ACTIVE_COMPARATOR): Femoral nerve catheter delivering 0.0625% L- Bupivacaine: Blockade at level of Femoral crease. Identify femoral nerve. In plane lateral approach. Bolus 20 mls via needle. Catheter threaded and 2-4cm left in situ (bevel orientated cephalad).and 5 mls injected via catheter to confirm spread under ultrasound guidance. Glue/Lockit dressing.
- Group A (Type: EXPERIMENTAL): Adductor canal catheter delivering 0.0625% L- Bupivacaine: Blockade at mid-thigh. Identify sartorius at mid thigh - find point where the femoral artery begins to descend from sartorius. In plane technique, hydro-dissect space between sartorius and femoral artery. Catheter threaded and 2-4cm left in situ (bevel orientated cephalad). Bolus 20 mls via needle and 5 mls via catheter to confirm spread under ultrasound guidance. Glue/Lockit dressing.

Based on this trial design, predict the completion outcome and termination type (if applicable).